Invesco S&P Ultra Dividend Revenue ETF (NY:RDIV)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Philip Morris Hits Record High On Q3 Earnings Beat: ETFs In Focus ↗
October 27, 2024
Ford's US Sales Edge Up In Q3; EV Sales Continue To Climb ↗
October 02, 2024
Ready For The Road - Ford Opens Orders For 2025 F-Series Super Duty Truck ↗
September 24, 2024
ChargeScape Powers Up: Ford, BMW, Honda Launch Vehicle-Grid Joint Venture ↗
September 18, 2024
What's Going On With Ford Motor Stock Today? ↗
September 11, 2024
What's Going On With Nordstrom Shares Thursday? ↗
September 05, 2024
What's Going On With Chemical Giant Dow Shares Today? ↗
April 25, 2024
What's Going On With PNC Financial Shares Today? ↗
April 16, 2024
Why Ford Motor Shares Are Falling Today ↗
April 12, 2024
Frequently Asked QuestionsIs Invesco S&P Ultra Dividend Revenue ETF publicly traded?
Yes, Invesco S&P Ultra Dividend Revenue ETF is publicly traded.
What exchange does Invesco S&P Ultra Dividend Revenue ETF trade on?
Invesco S&P Ultra Dividend Revenue ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco S&P Ultra Dividend Revenue ETF?
The ticker symbol for Invesco S&P Ultra Dividend Revenue ETF is RDIV on the New York Stock Exchange
What is the current price of Invesco S&P Ultra Dividend Revenue ETF?
The current price of Invesco S&P Ultra Dividend Revenue ETF is 59.37
When was Invesco S&P Ultra Dividend Revenue ETF last traded?
The last trade of Invesco S&P Ultra Dividend Revenue ETF was at 06/26/26 04:10 PM ET
What is the market capitalization of Invesco S&P Ultra Dividend Revenue ETF?
The market capitalization of Invesco S&P Ultra Dividend Revenue ETF is 9.72M
How many shares of Invesco S&P Ultra Dividend Revenue ETF are outstanding?
Invesco S&P Ultra Dividend Revenue ETF has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
